| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CENTB2 |
CENTB2, KIAA0041: Centaurin-beta 2 |
0.4 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.4 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ATM |
ATM: Serine-protein kinase ATM |
0.4 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
STK4 |
STK4, MST1: Serine/threonine-protein kinase 4 |
0.4 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
0.4 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
0.4 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
0.4 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
RPS6KB1 |
IPI00216132 |
0.4 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
TNC |
TNC, HXB: Tenascin precursor |
0.4 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
TOPBP1 |
TOPBP1, KIAA0259: DNA topoisomerase 2-binding protein 1 |
0.4 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
0.4 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
RPL3 |
RPL3, OK/SW-cl.32: 60S ribosomal protein L3 |
0.4 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
BRD2 |
BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
RPS6KB2 |
RPS6KB2, STK14B: Ribosomal protein S6 kinase beta-2 |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PRPF4B |
PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
0.4 |
Evidence |
O
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
0.4 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
RPS6KB1 |
IPI00216132 |
0.4 |
Evidence |
|
| VIL2 |
IPI00479359 |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.4 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
MAPKAPK3 |
MAPKAPK3: MAP kinase-activated protein kinase 3 |
0.4 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
SNX17 |
SNX17, KIAA0064: Sorting nexin-17 |
0.4 |
Evidence |
|